These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Severe toxicity after treatment with capecitabine and fluorouracil due to partial dihydropyrimidine dehydrogenase deficiency]. Hooiveld EA; van Kuilenburg AB; Haanen JB; Westermann AM Ned Tijdschr Geneeskd; 2004 Mar; 148(13):626-8. PubMed ID: 15083629 [TBL] [Abstract][Full Text] [Related]
12. Severe adverse events due to dihydropyrimidine dehydrogenase deficiency in a Japanese patient with colon cancer taking capecitabine: a case report. Tsutsui M; Yamamoto S; Yoshikawa Y; Nakanishi R; Takano K; Osumi K; Akatsu T; Yoneyama K; Nakagawa M; Kanai T Int Cancer Conf J; 2018 Oct; 7(4):125-129. PubMed ID: 31149530 [TBL] [Abstract][Full Text] [Related]
13. Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines. Meulendijks D; Henricks LM; van Kuilenburg AB; Jacobs BA; Aliev A; Rozeman L; Meijer J; Beijnen JH; de Graaf H; Cats A; Schellens JH Cancer Chemother Pharmacol; 2016 Oct; 78(4):875-80. PubMed ID: 27544765 [TBL] [Abstract][Full Text] [Related]
14. A Japanese Patient with Gastric Cancer and Dihydropyrimidine Dehydrogenase Deficiency Presenting with DPYD Variants. Ishiguro M; Takenaka R; Ogura K; Hiratsuka A; Takeda H; Kawai D; Tsugeno H; Fujiki S; Okada H Acta Med Okayama; 2020 Dec; 74(6):557-562. PubMed ID: 33361878 [TBL] [Abstract][Full Text] [Related]
15. Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency. Etienne-Grimaldi MC; Pallet N; Boige V; Ciccolini J; Chouchana L; Barin-Le Guellec C; Zaanan A; Narjoz C; Taieb J; Thomas F; Loriot MA; Eur J Cancer; 2023 Mar; 181():3-17. PubMed ID: 36621118 [TBL] [Abstract][Full Text] [Related]
16. Unpredicted severe toxicity after 5-fluorouracil treatment due to dihydropyrimidine dehydrogenase deficiency. Baek JH; Kim JG; Kim SN; Kim DH; Sohn SK; Hong YJ; Lee KB Korean J Intern Med; 2006 Mar; 21(1):43-5. PubMed ID: 16646564 [TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus enterocolitis in a patient with dihydropyrimidine dehydrogenase deficiency after capecitabine treatment: A case report. Inoue F; Yano T; Nakahara M; Okuda H; Amano H; Yonehara S; Noriyuki T Int J Surg Case Rep; 2019; 56():55-58. PubMed ID: 30831507 [TBL] [Abstract][Full Text] [Related]
18. Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: Assessment of a multiparametric approach. Boisdron-Celle M; Capitain O; Faroux R; Borg C; Metges JP; Galais MP; Kaassis M; Bennouna J; Bouhier-Leporrier K; Francois E; Baumgaertner I; Guerin-Meyer V; Cojocarasu O; Roemer-Becuwe C; Stampfli C; Rosenfeld L; Lecompte T; Berger V; Morel A; Gamelin E Semin Oncol; 2017 Feb; 44(1):13-23. PubMed ID: 28395758 [TBL] [Abstract][Full Text] [Related]
19. [Severe toxicity following capecitabine administration because of dihydropyrimidine deshydrogenase (DPD) deficiency]. Coursier S; Martelet S; Guillermet A; Emptoz J; Villier C; Bontemps H Gastroenterol Clin Biol; 2010 Mar; 34(3):218-23. PubMed ID: 20219304 [TBL] [Abstract][Full Text] [Related]
20. Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur). Casneuf V; Borbath I; Van den Eynde M; Verheezen Y; Demey W; Verstraete AG; Bm Claes K; Haufroid V; Geboes KP Acta Clin Belg; 2022 Apr; 77(2):346-352. PubMed ID: 33423619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]